Existing HIV RT inhibitors as potential AD therapeutics

Existing Hiv Rt Inhibitors As Potential Ad Therapeutics enters the Adult Cognitive Disease corpus through the work of Jerold Chun (submission 135), and is indexed here as one of the concepts that submission puts to work.

The argument it belongs to

Jerold Chun's submission is summarised in this corpus as:

GRADEs (Gene Recombination in Alzheimer's Disease Explanations) proposes that somatic gene recombination (SgR) in post-mitotic neurons creates thousands of APP genomic cDNA variants (gencDNAs), driven by reverse transcriptase activity. These pathogenic gencDNAs accumulate mosaically, producing toxic APP variant proteins that form the seeds of amyloid plaques and prion-like disease spreading.

Where it sits

The submission scores against the framework's convergence nodes as: transcriptional / epigenetic 8 · compensatory paradigm 2 · neuroimmune interface 2 · ApoE4 hub 2 · endosomal nexus 1 · cytoskeletal collapse 1.

Its declared subject matter: RNA-isoform-diversity, long-read-sequencing-AD, somatic-gene-recombination, PacBio-Kinnex, somatic gene recombination, genomic mosaicism, reverse transcriptase, gencDNA, retroviral mechanisms, APP variants, prion-like spreading, RT inhibitors.

Named by the same submission

5 other concepts enter the corpus through the same paper, so they cover adjacent ground: Brain DNA blueprint is altered in AD neurons · Retroviral-like mechanisms drive disease propagation · Somatic recombination creates pathogenic gene variants · Somatic Mosaicism in AD · Transcriptomic Isoform Complexity.

Assembled from the corpus rather than written: the summary is quoted from the submission that named it; the node scores are read from its dossier. It has not yet been expanded into an article.